Koyfin Home > Directory > Health Care > ANI Pharma Inc > Cost of Goods Sold

ANI Pharma Inc Cost of Goods Sold Chart (ANIP)

ANI Pharma Inc annual/quarterly Cost of Goods Sold from 2012 to 2020.
  • ANI Pharma Inc Cost of Goods Sold for the quarter ending June 06, 2020 was $19m a 22.25% increase of 4m year over year
  • ANI Pharma Inc Cost of Goods Sold for the last 12 months ending June 06, 2020 was $71m a 8.01% increase of 6m year over year
  • ANI Pharma Inc Annual Cost of Goods Sold for 2019 was $63m a -6.76% decrease of -4m from 2018
  • ANI Pharma Inc Annual Cost of Goods Sold for 2018 was $67m a -17.22% decrease of -12m from 2017
  • ANI Pharma Inc Annual Cost of Goods Sold for 2017 was $79m a 45.74% increase of 36m from 2016
Other Income Statement Metrics:
  • ANI Pharma Inc EBITDA for the quarter ending December 12, 2018 was $20m a 26.31% increase of 5m year over year
  • ANI Pharma Inc Net Income for the quarter ending December 12, 2018 was $5m a 58.56% increase of 3m year over year
  • ANI Pharma Inc Total Revenue for the quarter ending December 12, 2018 was $57m a 18.63% increase of 11m year over year
View Chart On Koyfin

Quarterly ANIP Cost of Goods Sold Data

06/2020$19m
03/2020$22m
12/2019$18m
09/2019$15m
06/2019$16m
03/2019$15m
12/2018$20m
09/2018$16m
06/2018$17m
03/2018$21m

Annual ANIP Cost of Goods Sold Data

2019$63m
2018$67m
2017$79m
2016$43m
2015$13m
2014$11m
2013$10m
2012$9m
2011$7m